A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung Cancer

NCT02450539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

159

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer Stage IV

Interventions

DRUG: Abemaciclib
DRUG: Docetaxel

Sponsor

Eli Lilly and Company